针对化学疗法效应的3D基因组,通过人环素向3D基因组
Minkang Tan1, Shengnan Sun1, Yuchen Liu2
1Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands.
概括
人环素药物通过干扰CTCF结合来破坏三维 (3D) 染色质折叠,提供了一种新的抗癌机制. 这种表观基因组调制针对3D基因组,可能有利于癌症患者.
科学领域:
- 基因组学就是基因组学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 异常的三维 (3D) 染色质折叠与癌症的发展有关.
- 人环素药物在癌症化疗中被广泛使用.
研究的目的:
- 为了研究人类环素药物对3D染色体结构的影响.
- 探索针对3D基因组的环素的治疗机制.
主要方法:
- 使用ATAC-seq和TOP2AChIP-seq评估色素结构.
- 在用 antracycline 治疗的 K562 细胞中进行 Hi-C 实验.
- 分析 AML 患者的染色质结构变化,这些患者接受了 antracyclines 治疗.
主要成果:
- 特定的环素通过抑制CTCF结合来破坏染色质循环.
- 观察到3D染色体组织的广泛变化,包括在Myc. locus.
- 在AML患者中染色质结构的变化与临床结果相关.
结论:
- 人类循环类药物作为选择性表观基因组调节剂,准3D基因组.
- 这些药物为异常3D染色体结构的癌症提供了个性化治疗的潜在机制.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


